Overview

Palonosetron and Blood Coagulation

Status:
Recruiting
Trial end date:
2020-12-15
Target enrollment:
0
Participant gender:
All
Summary
Palonosetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of palonosetron. The investigators therefore will perform the present study to measure the effect of palonosetron level using a rotational thromboelastometry test.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Treatments:
Palonosetron
Criteria
Inclusion Criteria:

- Healthy volunteers

- Age: 20 to 65 years

- Body weight > 50 kg

- Volunteers who provided informed consent

Exclusion Criteria:

- Hematologic disease

- Anticoagulant medication